Changes in antigenic expression of ascitic tumor cells induced by explantation into short-term culture |
|
Immunotherapy of autoimmunity and cancer: the penalty for success |
|
In this issue: Immunology of the eye--inside and out |
|
In vitro effects of cyclosporines A and G on activation of an autoimmune T cell line. |
|
Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways |
|
Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen |
|
Inhibition of T lymphocyte proliferation by retinal glial Müller cells: reversal of inhibition by glucocorticoids. |
|
Inhibitory peptide analogs derived from a major uveitogenic epitope protect from antiretinal autoimmunity by inducing type 2 and regulatory T cells |
|
Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. |
|
Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells |
|
Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity |
|
Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report |
|
The living eye "disarms" uncommitted autoreactive T cells by converting them to Foxp3(+) regulatory cells following local antigen recognition |
|
Localization in rats of genetic loci regulating susceptibility to experimental erosive arthritis and related autoimmune diseases |
|
Long-term culture of Muller cells from adult rats in the presence of activated lymphocytes/monocytes products |
|
A look at autoimmunity and inflammation in the eye |
|
Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis |
|
Mincle Activation and the Syk/Card9 Signaling Axis Are Central to the Development of Autoimmune Disease of the Eye. |
|
The mixed leukocyte reaction (MLR) in carp: Bidirectional and unidirectional MLR responses |
|
Monoclonal Antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) Inhibit Experimental Autoimmune Uveitis |
|
Mouse Models of Experimental Autoimmune Uveitis: Comparative Analysis of Adjuvant-Induced vs Spontaneous Models of Uveitis |
|
Murine postthymectomy autoimmune oophoritis develops in association with a persistent neonatal-like Th2 response. |
|
New perspectives on effector mechanisms in uveitis |
|
NK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-γ-IL-27 axis |
|
Non-Immunological Recognition and Killing of Xenogeneic Cells by Macrophages |
|
An Ocular Commensal Protects against Corneal Infection by Driving an Interleukin-17 Response from Mucosal γδ T Cells |
|
Ocular immune privilege |
|
Organ-resident, nonlymphoid cells suppress proliferation of autoimmune T-helper lymphocytes |
|
Pertussis toxin alters the innate and the adaptive immune responses in a pertussis-dependent model of autoimmunity |
|
Pertussis toxin inhibits induction of tissue-specific autoimmune disease by disrupting G protein-coupled signals |
|
Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity. |
|
The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes |
|
Regulation of Autoimmunity by the Microbiome |
|
Regulation of the interaction between Th1 and Th2 T cell clones to provide help for antibody productionin vivo |
|
Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice |
|
The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment |
|
Residues 1–20 of IRBP and Whole IRBP Elicit Different Uveitogenic and Immunological Responses in Interferon Gamma Deficient Mice |
|
Retina-specific T regulatory cells bring about resolution and maintain remission of autoimmune uveitis |
|
Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis |
|
The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model |
|
A simplified, competitive RT-PCR method for measuring rat IFN-gamma mRNA expression |
|
The Small Tellurium Compound AS101 Ameliorates Rat Crescentic Glomerulonephritis: Association with Inhibition of Macrophage Caspase-1 Activity via Very Late Antigen-4 Inactivation |
|
Specific activity of carp antisera against beta 2-microglobulin (beta 2m) and evidence for a beta 2m homologue in carp (Cyprinus carpio). |
|
Spontaneous autoimmunity prevented by thymic expression of a single self-antigen |
|
Spontaneous Ocular Autoimmunity in Mice Expressing a Transgenic T Cell Receptor Specific to Retina: A Tool to Dissect Mechanisms of Uveitis. |
|
STAT-3-independent production of IL-17 by mouse innate-like αβ T cells controls ocular infection. |
|
Susceptibility to autoimmune disease and drug addiction in inbred rats. Are there mechanistic factors in common related to abnormalities in hypothalamic-pituitary-adrenal axis and stress response function? |
|
Susceptibility to murine experimental autoimmune oophoritis is associated with genes outside the major histocompatibility complex (MHC). |
|
T cell receptor beta-chain usage in experimental autoimmune uveoretinitis |
|
Targeting CD6 for the treatment of experimental autoimmune uveitis. |
|
Targeting lymphotoxin depletes pathogenic T cells |
|
Tertiary Lymphoid Tissue Forms in Retinas of Mice with Spontaneous Autoimmune Uveitis and Has Consequences on Visual Function |
|
Tgf-beta inhibits activation and uveitogenicity of primary but not of fully polarized retinal antigen-specific memory-effector T cells |
|
Th1 and Th17 cells: adversaries and collaborators |
|
Transgenic expression of an immunologically privileged retinal antigen extraocularly enhances self tolerance and abrogates susceptibility to autoimmune uveitis |
|
Treatment of Uveitis by Oral Administration of Retinal Antigens: Results of a Phase I/II Randomized Masked Trial |
|
Tregitopes switch on Tregs |
|
Understanding autoimmunity in the eye: from animal models to novel therapies |
|
Use of optical coherence tomography and electroretinography to evaluate retinal pathology in a mouse model of autoimmune uveitis |
|
Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cells |
|
Uveitogenic T lymphocytes in the rat: pathogenicity vs. lymphokine production, adhesion molecules and surface antigen expression |
|
Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis |
|
Vaccination with autoantigen protects against aggregated beta-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cells |
|
ZIKA virus infection causes persistent chorioretinal lesions. |
|
שינויים אנטיגניים החלים בתאי טימור אסציטיביים : בעקבות הכנסתם לתרבית קצרת מועד. |
|